Wilmington, DE -- (SBWIRE) -- 10/24/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Celsion Corp. (NASDAQ:CLSN) and Mirati Therapeutics, Inc. (NASDAQ:MRTX).
Celsion Corp. (NASDAQ:CLSN) an oncology drug development company that focuses on the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology is currently up (+2.56%) on 5,127,442 shares traded after Celsion Corporation Provided Clinical Update on ThermoDox HEAT Study Findings. Celsion Corp. (NASDAQ:CLSN) is currently up (+74.67%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Celsion Corp. (NASDAQ:CLSN)
Mirati Therapeutics, Inc. (NASDAQ:MRTX) a biopharmaceutical company that engages in the development of therapeutics for the cancer treatment is currently down (-3.47%) on 949,489 shares traded after Mirati Therapeutics Priced Public Offering Of Common Stock. Mirati Therapeutics, Inc. (NASDAQ:MRTX) is currently down (-32.5%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Mirati Therapeutics, Inc. (NASDAQ:MRTX)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)